TCM
ELEV
Tang Capital Management’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,760,000
| Closed | -$1.23M | – | 208 |
|
|
2025
Q1 | $1.23M | Hold |
4,760,000
| – | – | 0.07% | 141 |
|
|
2024
Q4 | $2.68M | Hold |
4,760,000
| – | – | 0.18% | 95 |
|
|
2024
Q3 | $2.86M | Buy |
4,760,000
+1,700,000
| +56% | +$1.02M | 0.2% | 89 |
|
|
2024
Q2 | $8.26M | Hold |
3,060,000
| – | – | 0.84% | 39 |
|
|
2024
Q1 | $15.7M | Sell |
3,060,000
-607,600
| -17% | -$3.12M | 1.63% | 18 |
|
|
2023
Q4 | $1.97M | Sell |
3,667,600
-332,400
| -8% | -$178K | 0.18% | 93 |
|
|
2023
Q3 | $2.65M | Hold |
4,000,000
| – | – | 0.37% | 64 |
|
|
2023
Q2 | $6.08M | Buy |
4,000,000
+2,600,000
| +186% | +$3.95M | 0.9% | 32 |
|
|
2023
Q1 | $2.66M | Buy |
1,400,000
+920,146
| +192% | +$1.75M | 0.4% | 61 |
|
|
2022
Q4 | $456K | Buy |
+479,854
| New | +$456K | 0.07% | 76 |
|